TIA CARRINGTON: Open Payments
NPI 1982135943 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 26 payments from 8 companies in 2025. Trend: 2023 $463 · 2024 $871 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $179 |
| ABBVIE INC. | 14 | $164 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Lundbeck LLC | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Indivior Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, REXULTI, AUSTEDO XR, ABILIFY ASIMTUFII, SUBLOCADE, INGREZZA, UZEDY.
Industry payments across OH — which companies pay providers there.
